Personalized cell therapy takes on advanced cancers
NCT ID NCT06334783
First seen Jan 22, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tested a treatment called TIL therapy for people with advanced solid tumors. Doctors take immune cells from a patient's tumor, grow them in a lab, and put them back into the patient to attack the cancer. The goal was to check safety and see if tumors shrink. The study was stopped early after enrolling only 5 people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, Guangdong, China
-
Nanjing Jinling Hospital
Nanjing, Jiangsu, 210000, China
-
Wowen's hospital, School of medicine, Zhejiang University
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.